COL18A1

collagen type XVIII alpha 1 chain, the group of MicroRNA protein coding host genes|Collagens

Basic information

Region (hg38): 21:45405165-45513720

Previous symbols: [ "KNO" ]

Links

ENSG00000182871NCBI:80781OMIM:120328HGNC:2195Uniprot:P39060AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Knobloch syndrome 1 (Definitive), mode of inheritance: AR
  • Knobloch syndrome 1 (Strong), mode of inheritance: AR
  • Knobloch syndrome (Supportive), mode of inheritance: AR
  • Knobloch syndrome (Strong), mode of inheritance: AR
  • Knobloch syndrome 1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Glaucoma, primary, closed-angle; Knobloch syndrome 1AD/AROphthalmologicPrimary open-angle glaucoma can involve loss of vision, and awareness of disease risk may allow surveillance and early treatment; Knobloch syndrome can involve increased risk of retinal detachment, and awareness may allow early diagnosis and managementCraniofacial; Musculoskeletal; Neurologic; Ophthalmologic1554013; 7802003; 10942434; 14695535; 17546652; 19160445; 20799329; 21085708; 21862674; 21937992; 30007336

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the COL18A1 gene.

  • not provided (107 variants)
  • Knobloch syndrome (12 variants)
  • Knobloch syndrome 1 (5 variants)
  • Retinal dystrophy (3 variants)
  • COL18A1-related disorder (2 variants)
  • Cataract;Nystagmus;High myopia;Retinal dystrophy (2 variants)
  • Glaucoma, primary closed-angle (1 variants)
  • Retinitis pigmentosa (1 variants)
  • Macular dystrophy (1 variants)
  • Knobloch syndrome 1;Glaucoma, primary closed-angle (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the COL18A1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
58
clinvar
495
clinvar
48
clinvar
601
missense
1
clinvar
951
clinvar
56
clinvar
14
clinvar
1022
nonsense
20
clinvar
6
clinvar
26
start loss
0
frameshift
87
clinvar
7
clinvar
13
clinvar
107
inframe indel
38
clinvar
16
clinvar
7
clinvar
61
splice donor/acceptor (+/-2bp)
4
clinvar
31
clinvar
35
splice region
76
112
5
193
non coding
1
clinvar
111
clinvar
387
clinvar
198
clinvar
697
Total 111 46 1171 954 267

Highest pathogenic variant AF is 0.000952

Variants in COL18A1

This is a list of pathogenic ClinVar variants found in the COL18A1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
21-45405193-A-C Knobloch syndrome Uncertain significance (Jan 13, 2018)894996
21-45405204-C-G Knobloch syndrome Uncertain significance (Jan 13, 2018)894997
21-45405221-TG-T Likely benign (Apr 01, 2022)2652790
21-45405229-G-A Knobloch syndrome • not specified Uncertain significance (Oct 13, 2023)894998
21-45405235-C-T Uncertain significance (Feb 09, 2022)1472015
21-45405236-GC-G Pathogenic (Nov 28, 2021)1452520
21-45405239-G-A Likely benign (Aug 24, 2023)1529763
21-45405240-A-G Uncertain significance (Jun 13, 2022)1357447
21-45405241-G-A Uncertain significance (Dec 08, 2021)1437116
21-45405249-C-T Likely benign (Oct 18, 2022)2035854
21-45405249-CG-C Benign (Jun 18, 2023)1623986
21-45405250-G-T Likely benign (Nov 20, 2023)2049887
21-45405251-G-C Likely benign (Dec 18, 2023)2171202
21-45405255-T-C Likely benign (Jan 14, 2024)1663906
21-45405260-G-GGGTCC Likely benign (Jul 14, 2023)1572151
21-45405285-C-CGGCTGCGG Benign (May 11, 2021)1259241
21-45405285-C-CGGCTGCGGGGGCTGCGG Benign (May 11, 2021)1231149
21-45405299-G-C Benign (May 10, 2021)1277646
21-45405298-C-CCT Benign (May 11, 2021)1289798
21-45405308-G-C Benign (May 10, 2021)1268095
21-45405314-C-G Benign (May 10, 2021)1253503
21-45405320-C-T Benign (May 10, 2021)1277766
21-45405319-C-CTGGGT Benign (May 11, 2021)1276294
21-45405320-C-CCTGCGG Benign (May 11, 2021)1261044
21-45405327-TGCGGGGGTC-T Benign (May 11, 2021)1277042

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
COL18A1protein_codingprotein_codingENST00000355480 41108583
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.74e-101.0012469201191248110.000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.79710579871.070.00007009439
Missense in Polyphen311300.391.03532734
Synonymous-5.145674311.320.00003483344
Loss of Function4.943178.20.3970.00000416847

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009750.000922
Ashkenazi Jewish0.0001000.0000993
East Asian0.0003930.000389
Finnish0.0001460.000139
European (Non-Finnish)0.0005430.000512
Middle Eastern0.0003930.000389
South Asian0.0005650.000556
Other0.001760.00165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probably plays a major role in determining the retinal structure as well as in the closure of the neural tube. {ECO:0000269|PubMed:10942434}.; FUNCTION: Endostatin: Potently inhibits endothelial cell proliferation and angiogenesis (PubMed:9459295). May inhibit angiogenesis by binding to the heparan sulfate proteoglycans involved in growth factor signaling (By similarity). Inhibits VEGFA-induced endothelial cell proliferation and migration. Seems to inhibit VEGFA-mediated signaling by blocking the interaction of VEGFA to its receptor KDR/VEGFR2. Modulates endothelial cell migration in an integrin-dependent manner implicating integrin ITGA5:ITGB1 and to a lesser extent ITGAV:ITGB3 and ITGAV:ITGB5 (By similarity). May negatively regulate the activity of homotrimeric non-collagenous domain 1 (PubMed:11257123). {ECO:0000250|UniProtKB:P39061, ECO:0000269|PubMed:11257123, ECO:0000269|PubMed:9459295}.;
Disease
DISEASE: Knobloch syndrome 1 (KNO1) [MIM:267750]: A developmental disorder primarily characterized by typical eye abnormalities, including high myopia, cataracts, dislocated lens, vitreoretinal degeneration, and retinal detachment, with occipital skull defects, which can range from occipital encephalocele to occult cutis aplasia. {ECO:0000269|PubMed:10942434, ECO:0000269|PubMed:23667181}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Protein digestion and absorption - Homo sapiens (human);Assembly of collagen fibrils and other multimeric structures;Collagen chain trimerization;Collagen biosynthesis and modifying enzymes;Integrin cell surface interactions;Laminin interactions;Collagen degradation;Collagen formation;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Integrin;Degradation of the extracellular matrix;FOXA1 transcription factor network;Direct p53 effectors;Validated nuclear estrogen receptor alpha network;Beta1 integrin cell surface interactions (Consensus)

Intolerance Scores

loftool
0.155
rvis_EVS
0.74
rvis_percentile_EVS
86.36

Haploinsufficiency Scores

pHI
0.351
hipred
N
hipred_score
0.478
ghis
0.491

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.828

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Col18a1
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
col18a1a
Affected structure
neural crest cell migration
Phenotype tag
abnormal
Phenotype quality
process quality

Gene ontology

Biological process
angiogenesis;endothelial cell morphogenesis;cell adhesion;visual perception;positive regulation of cell population proliferation;negative regulation of cell population proliferation;animal organ morphogenesis;extracellular matrix organization;positive regulation of cell migration;response to drug;response to hydrostatic pressure;positive regulation of endothelial cell apoptotic process
Cellular component
extracellular region;collagen trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix;extracellular exosome
Molecular function
extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength;metal ion binding